1
Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
| Product Code | SHP77 |
| Species | Human |
| Cat.No | ABC-TC1319 |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Lung |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Human Lung Cancer Cell Lines |
SHP-77 is a human small cell lung carcinoma (SCLC) cell line established in 1977 from a non-encapsulated primary tumor in the apical upper lobe of the left lung of a 54-year-old Caucasian male patient. This cell line exhibits epithelial-like morphology with mixed growth properties, showing both loosely adherent clusters and suspension aggregates. Cytogenetic analysis reveals mutations in key oncogenic drivers including KRAS and TP53 (1). SHP-77 expresses various neuroendocrine differentiation markers such as L-dopa decarboxylase, dense core secretory granules, neural cell adhesion molecule (NCAM), and surface antigens CD56/CD57 (HNK-1/Leu-7). The cell line demonstrates tumorigenic potential in immunodeficient mice, making it valuable for studying SCLC progression and immunotherapy response.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
The SHP-77 cell line is a versatile research model widely used in immune-oncology and cytotoxicity studies related to small cell lung carcinoma (SCLC). It serves as an in vitro target in 51Cr and 111In release cytotoxicity assays, facilitating the study of cytotoxic immune responses. In vivo, SHP-77 is used in xenograft models to evaluate immune reactivity in nude mice, particularly using cells and serum from SCLC patients. Furthermore, they play a crucial role in assessing the immune status and therapeutic response in individuals with small cell lung carcinoma (SCLC) who have undergone radiation or chemotherapy treatments, offering valuable insights into treatment efficacy and resistance mechanisms.
